San Francisco, CA, United States of America

Justin Scheer

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.1

ph-index = 1


Location History:

  • San Francisco, CA (US) (2024)
  • South San Francisco, CA (US) (2024)

Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Justin Scheer: Innovator in Antibody Development

Introduction

Justin Scheer is a prominent inventor based in San Francisco, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of 3 patents, Scheer is recognized for his work that bridges science and medicine.

Latest Patents

One of Scheer's latest patents is titled "Humanized and affinity matured antibodies to FcRH5 and methods of use." This invention relates to anti-FcRH5 antibodies, which include an FcRH5 binding domain and a CD3 binding domain, specifically designed as FcRH5 T cell-dependent bispecific (TDB) antibodies. The methods of using these antibodies are also detailed in the patent. Another notable patent is "Production of heteromultimeric proteins using mammalian cells." This patent describes methods for the efficient production of antibodies and other multimeric protein complexes, collectively referred to as heteromultimeric proteins. These proteins are capable of specifically binding to multiple targets, which may include different epitopes located on a single molecule or on different molecules.

Career Highlights

Justin Scheer is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to contribute to groundbreaking research and development in the field of antibody therapies.

Collaborations

Some of Scheer's notable coworkers include J. Michael Elliott and Whitney Shatz. Their collaboration has likely fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Justin Scheer is a key figure in the development of advanced antibody therapies, with a focus on creating innovative solutions for complex medical challenges. His contributions to biotechnology continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…